Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10590076 Hepatitis B capsid assembly modulators

Patent 10590076 was granted and assigned to Venatorx Pharmaceuticals Inc. on March, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Thomas Haimowitz0

Bin Liu0

Christopher Benetatos0

Christopher J. Burns0

Glen Coburn0

Jiangchao Yao0

Stephen M. Condon0

Steven A. Boyd0

Date of Patent

March 17, 2020

0

Patent Application Number

164383610

Date Filed

June 11, 2019

0

Patent Citations Received

US Patent 12116356 N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, pharmaceutical composition thereof, and use thereof

0

US Patent 11566001 Hepatitis B capsid assembly modulators

US Patent 11008346 Beta-lactamase inhibitors

US Patent 11597716 N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, pharmaceutical composition thereof, and use thereof

US Patent 11247965 Hepatitis B capsid assembly modulators

US Patent 11414435 Beta-lactamase inhibitors

Patent Primary Examiner

Laura L. Stockton

0

Patent abstract

Described herein are hepatitis B capsid assembly modulators and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of hepatitis B.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10590076 Hepatitis B capsid assembly modulators

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool